Jiang, Shan
Yuan, Taolin
Rosenberger, Florian A. http://orcid.org/0000-0003-4604-6170
Mourier, Arnaud http://orcid.org/0000-0002-5413-611X
Dragano, Nathalia R. V.
Kremer, Laura S.
Rubalcava-Gracia, Diana http://orcid.org/0000-0002-4615-7375
Hansen, Fynn M.
Borg, Melissa
Mennuni, Mara
Filograna, Roberta
Alsina, David
Misic, Jelena
Koolmeister, Camilla
Papadea, Polyxeni http://orcid.org/0000-0002-5131-8196
de Angelis, Martin Hrabe
Ren, Lipeng
Andersson, Olov http://orcid.org/0000-0001-6715-781X
Unger, Anke http://orcid.org/0000-0003-1288-3763
Bergbrede, Tim http://orcid.org/0000-0002-0930-1884
Di Lucrezia, Raffaella http://orcid.org/0000-0001-6510-9945
Wibom, Rolf
Zierath, Juleen R. http://orcid.org/0000-0001-6891-7497
Krook, Anna http://orcid.org/0000-0002-0891-0258
Giavalisco, Patrick http://orcid.org/0000-0002-4636-1827
Mann, Matthias http://orcid.org/0000-0003-1292-4799
Larsson, Nils-Göran http://orcid.org/0000-0001-5100-996X
Funding for this research was provided by:
VetenskapsrÄdet (2015-00418)
Swedish Cancer Foundation (CAN2018/602)
Novo Nordisk Fonden (NNF20OC006316)
European Molecular Biology Organization (ALTF570-2019, ALTF399-2021)
Article History
Received: 3 November 2022
Accepted: 28 March 2024
First Online: 30 April 2024
Competing interests
: N.G.L. is a scientific founder and holds stock in Pretzel Therapeutic. T.B., A.U. and R.D.L. are employees of Lead Discovery Center and are co-inventors of the patent application WO 2019/057821. The remaining authors declare no competing interests.